ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Pear Therapeutics Announces FDA Submission for Somryst americanpharmaceuticalreview
July 19, 2019Pear Therapeutics announced the filing of a submission to the U.S. Food and Drug Administration (FDA) seeking marketing authorization for Somryst?, a prescription digital therapeutic (PDT) intended for use in the treatment of adults with chronic insomnia
Pharma Sources Insight January 2025
